Mettler-Toledo International Inc. — FY2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021. The supplied filing text reports annual results and does not provide a clear standalone fourth-quarter financial summary.
Business context
Mettler-Toledo is a global supplier of precision instruments and related services, including laboratory and industrial instruments, process analytics, and food-retail weighing solutions. Sales are diversified across customers and geographies; no single customer represented more than 1% of 2021 sales. Laboratory, industrial, and retail businesses represented approximately 56%, 39%, and 5% of sales, respectively.
Key financial metrics
| Metric | FY2021 | FY2020 |
|---|---|---|
| Net sales | $3.718 billion | $3.085 billion |
| Net sales growth | 21% reported; 18% in local currencies | 3% reported; 2% in local currencies |
| Gross profit / gross margin | $2.172 billion / 58.4% | $1.801 billion / 58.4% |
| Earnings before taxes | $949.4 million | $748.7 million |
| Net earnings | $769.0 million | $602.7 million |
| Diluted EPS | $32.78 | $24.91 |
| Operating cash flow | $908.8 million | $724.7 million |
| Capital expenditures | $107.6 million | $92.5 million |
| Total debt | $1.682 billion | $1.334 billion |
| Cash and cash equivalents | $98.6 million | $94.3 million |
Gross margin was flat year over year: higher volume and favorable pricing were offset by increased material and transportation costs and comparison with temporary cost savings in 2020. The reported tax rate was 19.0%, versus 19.5% in 2020. At year-end, approximately $649 million remained available under the $1.25 billion revolving credit facility; the company reported compliance with debt covenants.
Material changes versus FY2020
- Growth was broad-based, with particularly strong performance in China. Local-currency sales grew 25% in China and 20% in the Americas; Europe grew 12%.
- Laboratory sales increased 22% in local currencies; industrial sales increased 15%. Food-retail sales declined 6% in local currencies.
- Chinese Operations segment profit rose to $369.8 million from $270.5 million; total segment profit increased to $1.058 billion from $840.7 million.
- Operating cash flow increased by $184.1 million, primarily reflecting higher net earnings. Inventory rose to $414.5 million from $297.6 million.
- Debt increased, while the company spent $1.0 billion on share repurchases, compared with $775 million in 2020. Weighted-average diluted shares declined to 23.46 million from 24.20 million.
Outlook, management commentary, and risks
- Management described market conditions as favorable but noted difficult year-over-year comparisons ahead after strong 2021 results. It gave no specific 2022 revenue or EPS guidance in the supplied filing text.
- Management expects inflation in materials, transportation, and logistics to further pressure costs in 2022. The company plans continued pricing, productivity, market-penetration, and margin-improvement initiatives, and intends to spend a similar amount on share repurchases in 2022 as in 2021, subject to conditions.
- Supply-chain constraints, component shortages, transportation delays, and labor pressures remained risks despite the company generally meeting customer delivery requirements with some interruption. COVID-19, including new variants and potential lockdowns, could disrupt demand, operations, and supply.
- China is a significant concentration: Chinese Operations generated 21% of sales to external customers and 35% of segment profit in 2021. Management cautioned that emerging-market conditions, especially in China, can change quickly.
- In 2021, the company acquired PendoTECH for an initial $185.0 million plus post-closing payments, with potential additional consideration of up to $20.0 million, and acquired Scale-up Systems for $20.2 million, with possible additional payments. The PendoTECH contingent-consideration estimate was increased by $6.8 million during the year.
- The company expects $35.8 million of U.S. Department of Defense funding over two years to support domestic pipette-tip capacity and automation, offsetting future capital expenditures.
- Environmental remediation at a New Jersey site is expected to cost approximately $0.4 million over the next several years. Management said it did not expect current legal proceedings to materially affect results or financial condition, while noting possible future environmental liabilities.
Important facts for investors to verify
- Whether supply availability, freight costs, and inflation are affecting margins and delivery performance beyond management’s current assessment.
- Whether growth in China and other emerging markets remains durable, given China’s importance to sales, production, and segment profit.
- Debt repayment and refinancing needs, covenant headroom, and the funding mix for planned repurchases and investment.
- Realization of acquisition targets and the final amount of contingent consideration, particularly for PendoTECH.
- Changes in deferred-tax-asset realizability, tax exposures, and potential environmental or other contingencies.